CDEK
← All drugs Report issue

saw palmetto

Botanicalexperimental

Serenoa repens, commonly known as saw palmetto, is a small palm, growing to a maximum height around 200–300 cm (6.6–9.8 ft). — Wikipedia

Clinical trial activity

11 trials · 27 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
6
Phase 3
2
Phase 4
4

Earliest trial started Aug 1, 1999 (NCT00037154)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 3 Sponsor(trial)

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lg166s
  • lg 166-s
  • permixon
  • permixon
  • sabal
  • sabal
  • saw palmetto
  • saw palmetto
  • saw palmetto
  • saw palmetto
  • saw palmetto berry extract
  • saw palmetto extract
  • saw palmetto fruit
  • saw palmetto lipidic extract
  • serenoa preparation
  • serenoa repens
  • serenoa repens b extract

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04252625Phase 2Apr 30, 2020University of Utah
NCT02121613Phase 4Apr 1, 2014Pierre Fabre
NCT01604811Phase 4Jun 1, 2012Pierre Fabre
NCT02130713Phase 4Jan 1, 2012University of Roma La Sapienza
NCT01585246Phase 1/Phase 2 (Phase 2)Oct 1, 2011Michigan State University
NCT01021267Phase 4Nov 1, 2009Bioforce AG, University of London
NCT00797394Phase 2Nov 1, 2008innoVactiv Inc.
NCT00669656Phase 2Jul 6, 2008University of Southern California
NCT00603304Phase 3Feb 1, 2008Cornell University, Harvard University, Kaiser Permanente, National Center for Complementary and Integrative Health (NCCIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), New York University, Northwestern University, Office of Dietary Supplements (ODS), Queen's University, Belfast, The University of Texas, Dallas, University of Alabama, Birmingham, University of Colorado, Denver, University of Iowa, University of Maryland, Washington University in St. Louis, Yale University
NCT00497939N/AJan 1, 2006Chinese University of Hong Kong, Government of Hong Kong
NCT00037154Phase 3Aug 1, 1999Kaiser Permanente, National Center for Complementary and Integrative Health (NCCIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of California, San Francisco
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Kaiser PermanenteAcademic/Hospital2011999
National Center for Complementary and Integrative Health (NCCIH)Government2011999
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government2111999
Pierre FabreFor profit2212012
Bioforce AGFor profit1112009
Chinese University of Hong KongAcademic/Hospital1012006
Cornell UniversityAcademic/Hospital1012008
Government of Hong KongGovernment1112006
Harvard UniversityAcademic/Hospital1012008
innoVactiv Inc.For profit1112008
Michigan State UniversityAcademic/Hospital1112011
New York UniversityAcademic/Hospital1012008
Northwestern UniversityAcademic/Hospital1012008
Office of Dietary Supplements (ODS)Government1012008
Queen's University, BelfastAcademic/Hospital1012008
The University of Texas, DallasAcademic/Hospital1012008
University of Alabama, BirminghamAcademic/Hospital1112008
University of California, San FranciscoAcademic/Hospital1011999
University of Colorado, DenverAcademic/Hospital1012008
University of IowaAcademic/Hospital1012008
27 organizations
Page 1 / 2